BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 3298829)

  • 21. Pleural controversy: close needle pleural biopsy or thoracoscopy-which first?
    Koegelenberg CF; Diacon AH
    Respirology; 2011 Jul; 16(5):738-46. PubMed ID: 21435098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunocytochemical characterization of malignant mesothelioma and carcinoma metastatic to the pleura: IOB3--a new tumor marker.
    Kortsik CS; Werner P; Freudenberg N; Virchow JC; Kroegel C; Pott M; Matthys H
    Lung; 1995; 173(2):79-87. PubMed ID: 7536281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interpretation of pleural biopsy specimens and aspirates with the immunoperoxidase technique.
    Herbert A; Gallagher PJ
    Thorax; 1982 Nov; 37(11):822-7. PubMed ID: 6761889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An update of the long-term outcome of patients with nonspecific pleurisy at medical thoracoscopy.
    Yu YX; Yang Y; Wu YB; Wang XJ; Xu LL; Wang Z; Wang F; Tong ZH; Shi HZ
    BMC Pulm Med; 2021 Jul; 21(1):226. PubMed ID: 34253218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pleural effusion].
    Thomas P; Castelnau O; Kleisbauer JP
    Rev Mal Respir; 1998 Jun; 15(3 Pt 2):363-7. PubMed ID: 9690306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The value of exfoliative cell cytology in the diagnosis of exudative pleural effusions.
    Tetikkurt C; Yılmaz N; Tetikkurt S; Gundogdu Ş; Disci R
    Monaldi Arch Chest Dis; 2018 Sep; 88(3):944. PubMed ID: 30203633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal antibodies in the cytodiagnosis of serous effusions.
    al-Nafussi A; Carder PJ
    Cytopathology; 1990; 1(2):119-28. PubMed ID: 1714782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. P53-immunoreactive cells in benign and malignant effusions: diagnostic value using a panel of monoclonal antibodies and comparison with CEA-staining.
    Stoetzer OJ; Munker R; Darsow M; Wilmanns W
    Oncol Rep; 1999; 6(2):455-8. PubMed ID: 10023021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macroscopic characteristics of pleural metastases arising from the breast and observed by diagnostic thoracoscopy.
    Cantó-Armengod A
    Am Rev Respir Dis; 1990 Sep; 142(3):616-8. PubMed ID: 2389913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
    Klech H; Rona G; Hutter C; Bayer PM; Kummer F
    Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
    Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
    Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Yield of pleural biopsy in different types of tubercular effusions.
    Tousheed SZ; Ranganatha R; Kumar H; Sagar C; Manjunath PH; Philip D; Punita M; Hibare KR; Reddy M; Muralimohan BV
    Indian J Tuberc; 2020 Oct; 67(4):523-527. PubMed ID: 33077054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome of patients with nonspecific pleuritis/fibrosis on thoracoscopic pleural biopsies.
    Davies HE; Nicholson JE; Rahman NM; Wilkinson EM; Davies RJ; Lee YC
    Eur J Cardiothorac Surg; 2010 Oct; 38(4):472-7. PubMed ID: 20219385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective Study of the Utility of Computed Tomography Triage of Pleural Biopsy Strategies in Patients With Pleural Diseases.
    Metintas M; Ak G; Metintas S; Yildirim H; Dündar E; Rahman N
    J Bronchology Interv Pulmonol; 2019 Jul; 26(3):210-218. PubMed ID: 31211722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnostic value of the tumor markers TPA-M, CYPFRA 21-1 and CEA in pleural effusion. Prospective comparison of thoracoscopic investigations in patients with pleural effusion].
    Riedel U; Schönfeld N; Savaser A; Serk M; Loddenkemper R
    Pneumologie; 1999 Oct; 53(10):471-6. PubMed ID: 10596548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is there any role for thoracoscopy in the diagnosis of benign pleural effusions.
    Anevlavis S; Varga C; Nam TH; Man RWC; Demetriou A; Jain N; Lanfranco A; Froudarakis ME
    Clin Respir J; 2019 Feb; 13(2):73-81. PubMed ID: 30578625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases.
    Prakash UB; Reiman HM
    Mayo Clin Proc; 1985 Mar; 60(3):158-64. PubMed ID: 3974296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [CEA as a tumor marker on the cell surface and in the exudate. Comparison in thoracoscopy examined pleural effusions].
    Grosser H; Neubauer A; Musch R; Thalmann U; Huhn D; Loddenkemper R
    Pneumologie; 1990 Feb; 44 Suppl 1():529-30. PubMed ID: 2367457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Positive pleural cytology is an indicator for visceral pleural invasion in metastatic pleural effusions.
    Froudarakis ME; Plojoux J; Kaspi E; Anevlavis S; Laroumagne S; Karpathiou G; Roca E; Adler D; Dutau H; Astoul P
    Clin Respir J; 2018 Mar; 12(3):1011-1016. PubMed ID: 28245530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The usefulness of pleural biopsy in benign or malignant pleurisy].
    Inoue Y; Miura N; Watanabe T; Watanabe K; Tsutsumi T; Doutsu Y; Kohno S; Kanda T; Hirota M; Hara K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Mar; 29(3):332-7. PubMed ID: 2067153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.